Institute of Chemistry, Biological Chemistry and Chemometrics, Federal University of Rio Grande do Norte, Natal, 59072-970, Brazil.
Institute of Chemistry, Federal University of Goiás, Samambaia St., Goiânia, GO, 74690-900, Brazil.
Sci Rep. 2023 Mar 22;13(1):4658. doi: 10.1038/s41598-023-31565-0.
This study performs a chemical investigation of blood plasma samples from patients with and without fibromyalgia, combined with some of the symptoms and their levels of intensity used in the diagnosis of this disease. The symptoms evaluated were: visual analogue pain scale (VAS); fibromyalgia impact questionnaire (FIQ); Hamilton anxiety rating scale (HAM); Tampa Scale for Kinesiophobia (TAMPA); quality of life Questionnaire-physical and mental health (QL); and Pain Catastrophizing Scale (CAT). Plasma samples were analyzed by paper spray ionization mass spectrometry (PSI-MS). Spectral data were organized into datasets and related to each of the symptoms measured. The datasets were submitted to multivariate classification using supervised models such as principal component analysis with linear discriminant analysis (PCA-LDA), successive projections algorithm with linear discriminant analysis (SPA-LDA), genetic algorithm with linear discriminant analysis (GA-LDA) and their versions with quadratic discriminant analysis (PCA/SPA/GA-QDA) and support vector machines (PCA/SPA/GA-SVM). These algorithm combinations were performed aiming the best class separation. Good discrimination between the controls and fibromyalgia samples were observed using PCA-LDA, where the spectral data associated with the CAT symptom achieved 100% classification sensitivity, and associated with the VAS symptom achieved 100% classification specificity, with both symptoms at the moderate level of intensity. The spectral variable at 579 m/z was found to be substantially significant for classification according to the PCA loadings. According to the human metabolites database, this variable can be associated with a LysoPC compound, which comprises a class of metabolites already evidenced in other studies for fibromyalgia diagnosis. This study proposed an investigation of spectral data combined with clinical data to compare the classification ability of different datasets. The good classification results obtained confirm this technique is as a good analytical tool for the detection of fibromyalgia, and provides theoretical support for other studies about fibromyalgia diagnosis.
本研究对纤维肌痛症患者和非纤维肌痛症患者的血浆样本进行了化学研究,同时结合了一些用于诊断该疾病的症状及其严重程度。评估的症状包括:视觉模拟疼痛量表(VAS);纤维肌痛影响问卷(FIQ);汉密尔顿焦虑量表(HAM);运动恐惧症量表(TAMPA);生活质量问卷-身心健康(QL);和疼痛灾难化量表(CAT)。采用纸喷雾电离质谱(PSI-MS)对血浆样本进行分析。将光谱数据组织成数据集,并与所测量的每个症状相关联。将数据集提交给使用监督模型(如主成分分析与线性判别分析(PCA-LDA)、连续投影算法与线性判别分析(SPA-LDA)、遗传算法与线性判别分析(GA-LDA)及其二次判别分析版本(PCA/SPA/GA-QDA)和支持向量机(PCA/SPA/GA-SVM))的多元分类。这些算法组合的执行旨在实现最佳的分类分离。使用 PCA-LDA 观察到对照和纤维肌痛样本之间的良好区分,其中与 CAT 症状相关的光谱数据达到 100%的分类灵敏度,与 VAS 症状相关的光谱数据达到 100%的分类特异性,两个症状的强度均为中度。根据 PCA 载荷,发现 579 m/z 的光谱变量对分类具有实质性意义。根据人类代谢物数据库,该变量可与 LysoPC 化合物相关联,LysoPC 化合物是一类已在其他纤维肌痛症诊断研究中证实的代谢物。本研究提出了一种结合临床数据研究光谱数据的方法,以比较不同数据集的分类能力。获得的良好分类结果证实了该技术是检测纤维肌痛症的良好分析工具,并为其他纤维肌痛症诊断研究提供了理论支持。